Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 223

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 223
---
 agreements entered into in connection with the Debt Financing or any of the transactions contemplated thereby or the performance of any services thereunder will be
governed by New York law.

142

THE SUPPORT AGREEMENTS The discussion of the terms of the Support Agreements in this section and elsewhere in this Proxy Statement/Prospectus is qualified in its entirety by reference to the complete text of the form of Support Agreement, a copy of which is attached as Annex B to this Proxy Statement/Prospectus and is incorporated into this Proxy Statement/Prospectus by reference. This summary does not purport to be complete and may not contain all of the information about the Support Agreements that is important to you. You are encouraged to read the form of Support Agreement carefully and in its entirety. Concurrently with the execution and delivery of the Merger Agreement on January 10, 2025, and as a condition and inducement to Clearwater’s willingness to enter into the Merger Agreement, Clearwater entered into Support Agreements with each of the Significant Stockholders. Pursuant to its Support Agreement, each of the Significant Stockholders agreed, until the earlier to occur of the Effective Time and the valid termination of the Support Agreement in accordance with its terms, among other things, to:

| • |     | affirmatively vote all of the shares of (i) Enfusion Common Stock, (ii) Enfusion Class B Common                                                                                                                          
 Stock and (iii) Enfusion Common Units (all such shares and units beneficially owned by such Significant Stockholder, the “Subject Shares”), in favor of approving and adopting the Merger Agreement and the transactions 
 contemplated thereby; and/or                                                                                                                                                                                             |

| • |     | except as otherwise permitted by the Support Agreement, vote against: |

| • |     | any action or agreement which would reasonably be expected to |

| • |     | impede, materially delay or adversely affect the consummation of the Transactions or result in any of the          
 conditions to Enfusion’s obligations to consummate the Transactions not being fulfilled on or before the End Date; |

| • |     | result in a breach of any covenant, representation or warranty or any other obligation or agreement of Enfusion 
 contained in the Merger Agreement, or of such Significant Stockholder contained in the Support Agreement; or    |

| • |     | change in any manner the voting rights of any class of shares of Enfusion or Enfusion OpCo (including any 
 amendments to Enfusion’s certificate of incorporation or by